First Eagle US Value R6 FEVRX

Medalist Rating as of | See First Eagle Investment Hub
  • NAV / 1-Day Return 23.44  /  +0.13 %
  • Total Assets 1.4 Bil
  • Adj. Expense Ratio
    0.840%
  • Expense Ratio 0.840%
  • Distribution Fee Level High
  • Share Class Type Retirement, Large
  • Category Moderately Aggressive Allocation
  • Investment Style Large Value
  • Credit Quality / Interest Rate Sensitivity
  • Status Open
  • TTM Yield 1.26%
  • Turnover 7%

USD | NAV as of Sep 27, 2024 | 1-Day Return as of Sep 27, 2024, 10:12 PM GMT+0

Morningstar’s Analysis FEVRX

Will FEVRX outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

Sensible but not a standout.

Senior Analyst Chris Tate

Chris Tate

Senior Analyst

Summary

Though First Eagle US Value has the backing of an accomplished team, its risk-aware approach doesn’t utilize its breadth of expertise as well, given that it is limited to US equities.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings FEVRX

  • Current Portfolio Date
  • Equity Holdings
  • Bond Holdings
  • Other Holdings
  • % Assets in Top 10 Holdings 41.7
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Eligible Gold Bullion 100 T.O.

11.92 166.0 Mil

HCA Healthcare Inc

4.47 62.3 Mil
Healthcare

Oracle Corp

3.83 53.2 Mil
Technology

Meta Platforms Inc Class A

3.58 49.9 Mil
Communication Services

Philip Morris International Inc

3.46 48.2 Mil
Consumer Defensive

Elevance Health Inc

3.07 42.7 Mil
Healthcare

Universal Health Services Inc Class B

2.91 40.6 Mil
Healthcare

Bank of New York Mellon Corp

2.89 40.2 Mil
Financial Services

Colgate-Palmolive Co

2.80 38.9 Mil
Consumer Defensive

Exxon Mobil Corp

2.71 37.8 Mil
Energy

Sponsor Center